Clinical and Laboratory Evaluation of the Condition of the Oral Cavity in Children with Acute Leukemia
DOI:
https://doi.org/10.33295/1992-576X-2025-1-28Keywords:
dren, leukemia, phagocytic activity, phagocytic number, phagocytic index, oxygen-dependent phagocytosis (NBT-test).Abstract
Relevance: Leukemias are among the most common blood diseases in childhood. The state of the phagocytic system, the ability of phagocytic cells to absorb and digest microorganisms, significantly affects the development of various pathological diseases.
Objective: To study the features of the clinical course of acute leukemias and the features of phagocytosis in the oral cavity, using the indicators of the phagocytic index, phagocytic number, and oxygen-dependent phagocytosis (NBT-test) to establish the leading clinical symptoms and features of the phagocytic activity of phagocytic cells of the oral fluid.
Materials and methods. To achieve the set goals, 35 children aged 6 to 16 years with various forms of leukemia were examined. The subjects were divided into 2 groups: Group I — 19 children with acute lymphoblastic leukemia (ALL), of which 9 were in the first acute period, 4 in clinical remission, and 6 in relapse of the underlying disease; Group II — 16 children with acute myeloblastic leukemia (AML), of which 7 children were in the first acute period, 4 in clinical remission, and 5 children in relapse. Control group — 15 practically healthy children. Microscopic studies were performed, and the phagocytic activity of phagocytic cells of the oral fluid was studied.
Results: Fungal lesions of the oral mucosa were diagnosed in 67% of children at the stage of treatment of the first acute period. The value of the phagocytic index during this period was 85.7 ± 5.8%, PN — 21.1 ± 0.7, NBT test index — 40.4 ± 1.86. In the control group: PF — 70.0 ± 5.1%, PF — 3.9 ± 0.6, NST test index — 17.6 ± 1.23. PI in this period was 85.7 ± 5.8%, PN — 21.1 ± 0.7, NST test index — 40.4 ± 1.86. In the control group: PI — 70.0 ± 5.1 %, PN — 3.9 ± 0.6, NBT test index —17.6 ± 1.23.
At the stage of remission of ALL, gingivitis and candidiasis were the main clinical manifestations. The FI index was almost within normal limits — 73.8 ± 6, PN — 11.3 ± 0.6, NBT test — 23.7 ± 1.56.
During relapse of ALL, 83% of children were diagnosed with “chemotherapeutic stomatitis” and fungal lesions of the mucosa. The phagocytic activity index was 88.3 ± 4.8%, PN — 25.3, and NST index — 46.4.
At the stage of treatment of the first acute period of children with AML, fungal lesions of the oral mucosa were diagnosed in 71%, as well as hemorrhagic manifestations and acute herpetic stomatitis (28%). FI was 87.2%, FN — 16.1 ± 0.5, NBT — 41.6 ± 1.34. At the stage of remission of AML, gingivitis and fungal lesions of the oral mucosa were diagnosed in children. FI was 72.6 ± 5.9%. FN — 10.1 ± 0.4, NBT — 27.9 ± 1.86. During the period of relapse of AML, ulcerative-necrotic lesions of the mucous membrane, candidiasis, and hemorrhagic syndrome were detected in the oral cavity of children. FI was 89.1 ± 5.1, FN — 18.5 ± 0.2, NBT — 48.5 ± 1.05.
Conclusion. Fungal lesions of the oral mucosa are the most characteristic clinical manifestation in the oral cavity in acute leukemias. Ulcerative-necrotic oral mucosa lesions are more often clinical manifestations of blood diseases in AML. The phagocytic activity of neutrophils in the oral fluid is increased at the stage of treatment of the first acute period and the stage of relapse. The protective forces of the oral fluid in acute leukemias have a high activity level. However, the ability to destroy microbial cells is significantly lower than that of phagocytic capture.
Downloads
References
Cramer P, Tausch E, von Tresckow J, et al. Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood. 2021;138(19): 1805–1816. DOI: https://doi.org/10.1182/blood.2020010484
Li W, Wang F, Guo R, Bian Z, Song Y. Targeting macrophages in hematological malignancies: recent advances and future directions. J Hematol Oncol. 2022 Aug 17;15(1): 110. DOI: https://doi.org/10.1186/s13045-022-01328-x. PMID: 35978372; PMCID: PMC9387027.
Tam CS, Robak T, Ghia P, et al. Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion. Haematologica. 2021;106(9): 2354-2363. PMID: 33054121. DOI: https://doi.org/10.3324/haematol.2020.259432
Fürstenau M, Giza A, Weiss J, et al. Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial. 2024. Blood. Jul 18;144(3):272-282. DOI: https://doi.org/10.1182/blood.2023022730/PMID: 38620072.
Fürstenau M, Kater AP, Robrecht S, et al. First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2024 Jun;25(6): 744-759. DOI: https://doi.org/10.1016/S1470-2045(24)00196-7
Golpour M, Sohbatzadeh F, Alimohammadi M, Yazdani Z, Fattahi S, Zaboli E, Rafiei A, Bekeschus S. Increased Expression of ITGB 3 in CLL Patient leukemia Cells by Exposure to Cold Physical Plasma and Plasma-treated Medium. Int J Mol Cell Med. 2024;13(3): 248–258. PMID: 39493511. DOI: https://doi.org/10.22088/ijmcm.bums.13.3.248
Zlotnikov ID, Kudryashova EV. Biomimetic System Based on Reconstituted Macrophage Membranes for Analyzing and Selection of Higher-Affinity Ligands Specific to Mannose Receptor to Develop the Macrophage-Focused Medicines. Biomedicines. 2023 Oct 12;11(10): 2769. PMID: 37893142. DOI: https://doi.org/10.3390/biomedicines11102769
Tanim KM, Holtzhausen A, Thapa A, Huelse JM, Graham DK, Earp HS. MERTK Inhibition as a Targeted Novel Cancer Therapy. Int J Mol Sci. 2024 Jul 12;25(14): 7660. DOI: https://doi.org/10.3390/ijms25147660. PMID: 39062902
Uribe-Querol E, Rosales C. Phagocytosis: Our Current Understanding of a Universal Biological Process. Front Immunol. 2020 Jun 2;11: 1066. PMID: 32582172. DOI: https://doi.org/10.3389/fimmu.2020.01066
Lazarov T, Juarez-Carreño S, Cox N, Geissmann F. Physiology and diseases of tissue-resident macrophages. Nature. 2023 Jun;618(7966): 698–707. PMID: 37344646. DOI: https://doi.org/10.1038/s41586-023-06002-x
Nixon BG, Kuo F, Ji L, Liu M, Capistrano K, Do M, Franklin RA, Wu X, Kansler ER, Srivastava RM, Purohit TA, et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity. 2022 Nov 8;55(11): 2044-2058.e5. PMID: 36288724. DOI: https://doi.org/10.1016/j.immuni.2022.10.002
Brown GC. Cell death by phagocytosis. Nat Rev Immunol. 2024 Feb;24(2): 91-102. PMID: 37604896. DOI: https://doi.org/10.1038/s41577-023-00921-6
Voloshchuk, Oksana. Imunolohiia: navchalno-metodychnyi posibnyk/ukl. Voloshchuk O.M. — Chernivtsi: Chernivetskyi natsionalnyi universytet, Book. 2021. — 128 s. URL: https://archer.chnu.edu.ua/xmlui/handle/123456789/2894
Michael T. Madigan, John M. Martinko, Jack Parker. Brock Biology of Microorganisms. Brock Biology of Microorganisms, 10th Ed Prentice Hall international editions. Michael T. Madigan, John M. Martinko, Jack Parker. 2003. 1019 р.
N.M. Ilenko, O.V. Sheshukova, T.V. Polishchuk ta in. Osnovni pytannia kandydoznoi infektsii slyzovoi obolonky porozhnyny rota v dytiachomu ta doroslomu vitsi; navch. posibnyk. Poltava, 2023. 165s. URL: https://repository.pdmu.edu.ua/server/api/core/bitstreams/b6ab888a-be11-425f-a091-b34283bb77ef/content
Sokolova I. I., Herman S. I., Tomilina T. V., Savelieva N. M., Slynko Yu. O., Skydan K. V. Imunolohiia v suchasnii stomatolohii : metod. posibnyk dlia studentiv stomat. fak-tu, likariv-interniv-stomatolohiv ta likariv stomat. profiliu. Kharkiv, 2018. 116 s. URL: https://repo.knmu.edu.ua/server/api/core/bitstreams/2525f0e0-8f35-4edb-8676-c4b62f3f483a/content
Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A. The Neutrophil. Immunity. 2021 Jul 13;54(7): 1377–1391. PMID: 34260886. DOI: https://doi.org/10.1016/j.immuni.2021.06.006
Jauslin T, Lamrabet O, Crespo-Yañez X, Marchetti A, Ayadi I, Ifrid E, Guilhen C, Leippe M, Cosson P. How Phagocytic Cells Kill Different Bacteria: a Quantitative Analysis Using Dictyostelium discoideum. mBio. 2021 Feb 16;12(1): e03169-20. PMID: 33593980. DOI: https://doi.org/10.1128/mbio.03169-20
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 “VYDAVNYCHYY BUDYNOK EXPERT” LLC

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.